These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Enhanced exon 2 skipping caused by c.910G>A variant and alternative splicing of MEFV genes in two independent cases of familial Mediterranean fever. Tone Y; Toma T; Toga A; Sakakibara Y; Wada T; Yabe M; Kusafuka H; Yachie A Mod Rheumatol; 2012 Feb; 22(1):45-51. PubMed ID: 21562927 [TBL] [Abstract][Full Text] [Related]
13. Apoptosis-associated speck-like protein containing a CARD (ASC) expression profiles in familial Mediterranean fever (FMF) patients with different MEFV mutation patterns. Nalbantoglu S; Tanyolac B; Berdeli A Scand J Rheumatol; 2013; 42(2):159-62. PubMed ID: 22934972 [TBL] [Abstract][Full Text] [Related]
14. Familial Mediterranean Fever in Crete: a genetic and structural biological approach in a population of 'intermediate risk'. Fragouli E; Eliopoulos E; Petraki E; Sidiropoulos P; Aksentijevich I; Galanakis E; Kritikos H; Repa A; Fragiadakis G; Boumpas D; Goulielmos GN Clin Genet; 2008 Feb; 73(2):152-9. PubMed ID: 18177465 [TBL] [Abstract][Full Text] [Related]
15. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome. Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788 [TBL] [Abstract][Full Text] [Related]
16. Activated phenotype of circulating neutrophils in familial Mediterranean fever. Manukyan G; Petrek M; Kriegova E; Ghazaryan K; Fillerova R; Boyajyan A Immunobiology; 2013 Jun; 218(6):892-8. PubMed ID: 23182715 [TBL] [Abstract][Full Text] [Related]
17. The Assessment of Selected miRNA Profile in Familial Mediterranean Fever. Kahraman CY; Egin ME; Tatar A; Turkez H; Mardinoglu A Biomed Res Int; 2021; 2021():6495700. PubMed ID: 34692839 [TBL] [Abstract][Full Text] [Related]
18. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Yigit S; Karakus N; Tasliyurt T; Kaya SU; Bozkurt N; Kisacik B Gene; 2012 Sep; 506(1):43-5. PubMed ID: 22771921 [TBL] [Abstract][Full Text] [Related]
19. Musculoskeletal manifestations occur predominantly in patients with later-onset familial Mediterranean fever: Data from a multicenter, prospective national cohort study in Japan. Endo Y; Koga T; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Umeda M; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Agematsu K; Yachie A; Masumoto J; Migita K; Kawakami A Arthritis Res Ther; 2018 Nov; 20(1):257. PubMed ID: 30458853 [TBL] [Abstract][Full Text] [Related]
20. Potential of miRNAs to predict and treat inflammation from the perspective of Familial Mediterranean Fever. Balci-Peynircioglu B; Akkaya-Ulum YZ; Akbaba TH; Tavukcuoglu Z Inflamm Res; 2019 Nov; 68(11):905-913. PubMed ID: 31342094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]